These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 19654138

  • 1. Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction.
    Lula JF, Rocha MO, Nunes Mdo C, Ribeiro AL, Teixeira MM, Bahia MT, Talvani A.
    Eur J Heart Fail; 2009 Sep; 11(9):825-31. PubMed ID: 19654138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
    Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, Ben Gal Y, Keren G, George J.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1018-24. PubMed ID: 15808757
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy.
    Schoppet M, Ruppert V, Hofbauer LC, Henser S, Al-Fakhri N, Christ M, Pankuweit S, Maisch B.
    Biochem Biophys Res Commun; 2005 Dec 30; 338(4):1745-50. PubMed ID: 16288714
    [Abstract] [Full Text] [Related]

  • 6. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 7. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.
    Mocelin AO, Issa VS, Bacal F, Guimarães GV, Cunha E, Bocchi EA.
    Eur J Heart Fail; 2005 Aug 01; 7(5):869-73. PubMed ID: 16043406
    [Abstract] [Full Text] [Related]

  • 8. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.
    Tashiro H, Itamoto T, Ohdan H, Arihiro K, Tateaki Y, Nakahara H, Ochi M, Hino H, Mizunuma K, Hara H, Tokita D, Onoe T, Ishiyama K, Mitsuta H, Sugino K, Asahara T.
    Transpl Int; 2004 Nov 01; 17(10):626-33. PubMed ID: 15502938
    [Abstract] [Full Text] [Related]

  • 9. Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.
    Pelli N, Floreani A, Torre F, Delfino A, Baragiotta A, Contini P, Basso M, Picciotto A.
    Clin Exp Immunol; 2007 Apr 01; 148(1):85-9. PubMed ID: 17302732
    [Abstract] [Full Text] [Related]

  • 10. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy.
    Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM.
    Clin Infect Dis; 2004 Apr 01; 38(7):943-50. PubMed ID: 15034825
    [Abstract] [Full Text] [Related]

  • 11. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 01; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 12. High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas.
    Sanlioglu AD, Dirice E, Elpek O, Korcum AF, Balci MK, Omer A, Griffith TS, Sanlioglu S.
    Pancreas; 2008 May 01; 36(4):385-93. PubMed ID: 18437085
    [Abstract] [Full Text] [Related]

  • 13. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients.
    Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E.
    Mem Inst Oswaldo Cruz; 2003 Apr 01; 98(3):407-11. PubMed ID: 12886425
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
    Boffa GM, Zaninotto M, Nalli C, Forni M, Tiso E, Razzolini R, Plebani M.
    Ital Heart J; 2004 Jan 01; 5(1):48-52. PubMed ID: 15080581
    [Abstract] [Full Text] [Related]

  • 15. Lack of association of tumor necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients.
    Drigo SA, Cunha-Neto E, Ianni B, Mady C, Faé KC, Buck P, Kalil J, Goldberg AC.
    Immunol Lett; 2007 Jan 15; 108(1):109-11. PubMed ID: 17141882
    [Abstract] [Full Text] [Related]

  • 16. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S, Abraham P, Daniel HD, Ramakrishna BS, Sridharan G.
    J Clin Virol; 2005 Sep 15; 34(1):63-70. PubMed ID: 16087126
    [Abstract] [Full Text] [Related]

  • 17. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis.
    Hofbauer LC, Schoppet M, Christ M, Teichmann J, Lange U.
    Rheumatology (Oxford); 2006 Oct 15; 45(10):1218-22. PubMed ID: 16574701
    [Abstract] [Full Text] [Related]

  • 18. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J, Pacher R, Frey B, Kos T, Woloszczuk W, Stanek B.
    J Heart Lung Transplant; 1998 Apr 15; 17(4):356-62. PubMed ID: 9588580
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M.
    Ann Rheum Dis; 2005 Jun 15; 64(6):854-8. PubMed ID: 15564310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.